AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $515,000 | +20.3% | 47,952 | +6.0% | 0.00% | +50.0% |
| Q1 2022 | $428,000 | -86.2% | 45,246 | -83.1% | 0.00% | -88.2% |
| Q4 2021 | $3,094,000 | -46.0% | 267,846 | -55.3% | 0.02% | -54.1% |
| Q3 2021 | $5,729,000 | -36.7% | 599,845 | -36.1% | 0.04% | -41.3% |
| Q2 2021 | $9,049,000 | -48.0% | 938,732 | -46.7% | 0.06% | -50.4% |
| Q1 2021 | $17,407,000 | +354.7% | 1,761,865 | +962.7% | 0.13% | +296.9% |
| Q4 2020 | $3,828,000 | +194.7% | 165,793 | +80.2% | 0.03% | +190.9% |
| Q3 2020 | $1,299,000 | -8.8% | 91,996 | -2.6% | 0.01% | -31.2% |
| Q2 2020 | $1,425,000 | +67.6% | 94,475 | +2.8% | 0.02% | -33.3% |
| Q1 2020 | $850,000 | -84.4% | 91,945 | -74.6% | 0.02% | -80.3% |
| Q3 2017 | $5,466,000 | +80.2% | 362,440 | +20.4% | 0.12% | +60.5% |
| Q2 2017 | $3,033,000 | – | 301,143 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |